Full Year 2020 Cochlear Ltd Earnings Call Transcript
Good morning, everybody, and thank you for joining for our F '20 results presentation. So I'm going to give a bit of an overview with some highlights for the results, then hand over to Brent who will talk through some of the financial detail. And we'll come back to me to wrap up on strategy and outlook and then move on to Q&A.
Okay. Let's go. So I'll just start with our mission this time around. And our mission has always been important for us but I think never more so than in the last few months where we've had to navigate COVID-19, and it's really, I think, helped us keep our people focused on our customers and focused on building awareness and the work that we do to strengthen our product portfolio year-on-year.
Just to jump into an overview. You would have had a look at the results by now, see that we had a $238 million loss on the back of the patent litigation and the reduction in sales coming from COVID-19. You can see that, obviously, COVID-19 hit us pretty hard in the second half with our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |